SHENZHEN, China, May 22, 2025 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, they announced significant progress in the field of quantum-enhanced imaging based on nonlocal effects. This achievement has not only been validated in a laboratory setting but has also demonstrated advantages over traditional imaging in practical technical implementations. Compared to conventional phase imaging systems, HOLO leverages quantum-enhanced holograp ...

HIKMICRO announces the HABROK 4K Multi-Spectrum Binoculars, combining 4K UHD digital imaging, thermal detection, and night vision in a compact device. Designed for hunters and wildlife observers, it delivers clear, stable viewing and advanced features for reliable performance from daylight through complete darkness. Photo Courtesy of HIKMICRO HANGZHOU, China, May 16, 2025 (GLOBE NEWSWIRE) -- The launch of the HABROK 4K Multi-Spectrum Binoculars marks a new era for hunters, wildlife observers, and outdoor p ...

LightPath (LPTH) Q3 2025 Earnings Call May 15, 2025 05:00 PM ET Company Participants Sam Rubin - President and CEOAlbert Miranda - CFOBrian Kinstlinger - MD, Director of Research & Head of Technology Research Conference Call Participants Glenn Mattson - AnalystJaeson Schmidt - Director of Research - Senior Research AnalystRichard Shannon - Senior Research AnalystScott Buck - Managing Director & Senior Technology Analyst Operator Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Lig ...

Financial Data and Key Metrics Changes - Revenue for Q3 2025 increased by 19.1% to $9.2 million compared to $7.7 million in the same quarter of the previous year [31] - Gross profit rose by 66% to $2.7 million, representing 29.1% of total revenues, up from 20.9% in the same quarter last year [32] - Operating expenses increased by 44% to $6 million, primarily due to higher legal consulting fees and costs associated with the G5 acquisition [32] - Net loss for the quarter totaled $3.6 million, compared to a loss of $2.6 million in the same quarter last year [33] - Cash and cash equivalents as of March 31, 2025, totaled $6.5 million, up from $3.5 million as of June 30, 2024 [33] Business Line Data and Key Metrics Changes - Revenue from infrared components was $3.6 million (40% of total revenue), visible components at $2.8 million (31%), assemblies and modules at $1.9 million (20%), and engineering services at $800,000 (9%) [31] - The new direction of the company, including optical assemblies and cameras, now accounts for roughly 50% of revenue, with the other half from optical components [7][8] Market Data and Key Metrics Changes - The company has seen strong growth in demand for its proprietary Black Diamond materials, leading to the need for increased manufacturing capacity [16] - The company has reduced its exposure to risks associated with tariffs and recession in China, with 45% of headcount and 56% of footprint now in the U.S. [20][21] Company Strategy and Development Direction - The company is transitioning from a pure component supplier to a vertically integrated global solution provider for infrared imaging technologies [5] - Recent acquisitions, including G5 infrared, are expected to enhance the company's product offerings and revenue potential, particularly in defense applications [35] - The company aims to achieve long-term goals of 15% EBITDA margins and sustained growth [37] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, driven by geopolitical tensions and new product launches [5][39] - The company is focused on optimizing internal supply chains and engaging with customers regarding supply chain resilience [22] - Management acknowledged potential challenges related to supply chain and material availability but remains optimistic about the company's positioning [23][24] Other Important Information - The G5 acquisition is expected to generate $51 million in revenue in the twelve months following the acquisition, with new bookings of $13 million since the acquisition [35] - The company is integrating G5 and leveraging its expertise to maximize revenues and earnings [34] Q&A Session Summary Question: Can you discuss the delays related to the Apache program? - Delays were due to the complexity of the project and unexpected demand in other areas, not due to customer issues [41][42] Question: What is the status of the new fast-paced project related to BD glass? - The project is progressing quickly with government support, and it is expected to generate significant revenue once in production [44][45] Question: What is the outlook for gross margins in the next quarter? - Gross margins are expected to increase due to a full quarter of higher-margin products from G5 [48][49] Question: What is the backlog number as of March? - The backlog totaled $27.4 million [52] Question: What is the status of the Navy and border security contracts? - The Navy contract has been awarded, while the border security contract is more complex and involves multiple suppliers [99][100] Question: How is G5 tracking towards its revenue targets? - G5 is on course to meet its revenue targets, with no red flags observed so far [111][112]

ORLANDO, Fla., May 15, 2025 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal third quarter ended March 31, 2025.Financial Summary: Three Months Ended March 31, $ in millions 2025 2024 % Change Revenue $9.2 $7.7 19.1 % Gross Profit $2.7 $1.6 65.9 % Operating Expenses $ ...

Press ReleaseNokia and Celesta Capital launch Astranu to advance healthcare imaging technology Startup spin-out from Nokia Bell Labs will commercialize advanced healthcare imaging technology.Venture is the first in a Nokia – Celesta collaboration aiming to create a pipeline of spin outs from Nokia Bell Labs technologies.Astranu’s transformative technology delivers a highly performant, cost-effective imaging system for rapid and accurate 3D imaging of middle-ear conditions and hearing response. 15 May 2025Mu ...

30+ studies across diverse conditions illuminate the unique value of functional lung imaging with Xenon MRIDURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging ("MRI") of the lungs, will be featured at the American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit (RIS), taking place May 16–17 at the Marriott Marquis in San Francisco, Cali ...

Core Viewpoint - FONAR Corporation reported its financial results for the third quarter and nine-month period of fiscal 2025, highlighting growth in revenues but a decline in income from operations and net income for the nine-month period compared to the previous year [2][3][7]. Financial Performance - Total Revenues-Net for the quarter ended March 31, 2025, increased by 6% to $27.2 million compared to $25.7 million for the same quarter in 2024 [3][10]. - Total Revenues-Net for the nine-month period ended March 31, 2025, was $77.1 million, slightly up from $76.9 million for the same period in 2024 [3][50]. - Income From Operations for the quarter decreased by 2% to $3.66 million compared to $3.75 million for the same quarter in 2024 [6][10]. - Income From Operations for the nine-month period decreased by 30% to $10.7 million compared to $15.2 million for the same period in 2024 [6][50]. - Net Income for the quarter increased by 24% to $3.1 million compared to $2.5 million for the same quarter in 2024 [7][10]. - Net Income for the nine-month period decreased by 25% to $9.3 million compared to $12.5 million for the same period in 2024 [7][11]. Cost Analysis - Selling, general & administrative costs (SG&A) increased by 5% to $8.0 million for the quarter compared to $7.6 million in the same quarter of 2024 [4][10]. - SG&A costs increased by 11% to $20.1 million for the nine-month period compared to $18.0 million for the same period in 2024 [4][50]. - Total Costs and Expenses for the quarter were $23.5 million, up from $22.0 million in the same quarter of 2024 [5][10]. - Total Costs and Expenses for the nine-month period were $66.4 million compared to $61.7 million for the same period in 2024 [5][50]. Balance Sheet Highlights - Total Cash, Cash Equivalents, and Short-Term Investments decreased by 4% to $54.4 million as of March 31, 2025, compared to $56.5 million at June 30, 2024 [10][12]. - Total Current Assets increased to $141.1 million as of March 31, 2025, compared to $140.3 million at June 30, 2024 [12]. - Total Assets increased to $214.9 million as of March 31, 2025, compared to $214.2 million at June 30, 2024 [12][13]. - Total Current Liabilities decreased to $14.0 million as of March 31, 2025, compared to $17.9 million at June 30, 2024 [12][13]. Operational Achievements - The Health Management Company of America (HMCA) set a new record by completing 54,612 MRI scans in the third quarter of Fiscal 2025, which was 2.8% higher than the previous quarter and 3.4% higher than the same quarter in Fiscal 2024 [16]. - HMCA managed 44 MRI scanners, with plans to add more facilities to expand its network in New York and Florida [16][17]. Shareholder Actions - As of March 31, 2025, FONAR repurchased 373,942 shares at a cost of $6.07 million as part of its stock repurchase plan announced in September 2022 [17].

AI-Powered, Portable Brain MRI The Swoop® Portable MR Imaging® system is driving the future of brain health. Corporate Investor Deck – May 2025 Hyperfine, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. PROPERTY OF HYPERFINE, INC. ©2025. All rights reserved. PROPERTY OF HYPERFINE, INC. ©2025. All rights reserved. Forward-looking Statements This presentation includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigatio ...

Award recognizes Novasight Hybrid™ System’s significant advance in intracoronary imaging technologyTORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that its Novasight Hybrid™ System (“Novasight”) has been named "Product Innovation of the Year" at the 2025 Min ...